Propynyl (drug)

Propynyl
Clinical data
Other namesPROPYNYL; 4-Propynyloxy-3,5-dimethoxyphenethylamine; Propynylmescaline; Propynylscaline
Routes of
administration
Oral
Drug classPsychoactive drug
ATC code
  • None
Pharmacokinetic data
Duration of action8–12 hours
Identifiers
  • 2-{3,5-dimethoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}ethan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17NO3
Molar mass235.283 g·mol−1
3D model (JSmol)
  • COc1cc(cc(OC)c1OCC#C)CCN
  • InChI=1S/C13H17NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h1,8-9H,5-7,14H2,2-3H3 Y
  • Key:KNIWBMMJSJHUJB-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Propynyl, also known as 4-propynyloxy-3,5-dimethoxyphenethylamine or as propynylscaline, is a psychoactive drug of the scaline family related to mescaline. It is the derivative of mescaline in which the methoxy group at the 4 position has been replaced with a propynyloxy group.

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists propynyl's dose as 80 mg or more orally and its duration as 8 to 12 hours. The effects of propynyl have been reported to include "[not] that much mental stuff", obviously altered behavior, body load, physical fuzziness, cold feet, and next-day hangover or after-effects such as sluggishness. The drug produced no visual changes or closed-eye visuals, and clear hallucinogenic effects were not described. Higher doses than 80 mg orally were not explored, but there was no suggestion of value in exploring higher levels.

The chemical synthesis of propynyl has been described. Analogues of propynyl include mescaline, escaline, proscaline, allylescaline, and methallylescaline, among others.

Propynyl was first described in the literature by Shulgin in PiHKAL in 1991. It is not a controlled substance in Canada as of 2025.